NTU Course
NewsHelpOverview

Vaccine Policy and Immunization Practices

Offered in 112-2

  • Serial Number

    53212

  • Course Number

    EPM5058

  • Course Identifier

    849 U0580

  • No Class

  • 2 Credits

  • Compulsory / Elective

    Infectious Diseases Program / DEPARTMENT OF PUBLIC HEALTH / Graduate Institute of Epidemiology and Preventive Medicine

      Compulsory

    • Infectious Diseases Program

      • Elective

    • DEPARTMENT OF PUBLIC HEALTH

    • Graduate Institute of Epidemiology and Preventive Medicine

  • DING-PING LIU
  • Wed 6, 7

  • PUBLIC HEALTH BLDG. ROOM 211 (公衛211)

  • Type 2

  • 30 Student Quota

    NTU 28 + non-NTU 2

  • No Specialization Program

  • Chinese
  • NTU COOL
  • Core Capabilities and Curriculum Planning
  • Notes

  • NTU Enrollment Status

    Loading...
  • Course Description
    The course explores the key elements of a successful national immunization program: vaccine R&D and manufacture, vaccine policy and funding, immunization recommendation and evaluation, vaccine purchasing and cold chain, first-line immunization practice and management of adverse events. All of these elements are essential and link with one another. By introducing domestic and international examples, site visit, case study, exercise and experience sharing, a whole picture of immunization in the real world of public health will be displayed for students.
  • Course Objective
    At the end of the course the students are expected to 1. Understand the role and contents of various disciplines in preventive medicine. (I) 2. Understand human right and ethical issues related to preventive medicine strategies and research. (K) 3. Understand key issues for vaccine policy and immunization practices.
  • Course Requirement
    This is an advanced course in vaccinology. With credits of “Vaccinology” (by Dr. Yi-Chin Fan), “Microbiology and Immunology”, or basic training of immunology is preferred but not required.
  • Expected weekly study hours after class
  • Office Hour
    Wed15:00 - 16:00

    請於週一前先行預約。

  • Designated Reading
  • References
    1. The Vaccine Book, 2nd Edition. 2016. Edited by Barry R. and Paul-Henri Lambert. Elsevier. 2. The Pink Book: Epidemiology and Prevention of Vaccine-Preventable Diseases. Course Textbook - 14th Edition (2021). US CDC. (Available on website) 3. Plotkin's Vaccines. 7th Edition. 2018. Edited by Stanley A. Plotkin, Walter A. Orenstein, ... Kathryn M. Edwards. Elsevier. 4. 感染與疫苗. 行政院衛生署疾病管制局、台灣兒科醫學會、台灣感染症醫學會編輯. 2013年行政院衛生署疾病管制局出版. (Available on website)
  • Grading
    30%

    Participation

    出席與課程參與狀況

    30%

    Exercise

    (1) Students should apply their knowledge about the epidemiology of vaccine-preventable diseases, and weigh the strength and weakness of key elements of immunization in Taiwan to come to the conclusion. (2) The students should consider the benefits of all population, especially the vulnerable.

    40%

    Class discussion

    Students should describe their opinions and observation clearly, and make criticism with logical thinking independently.

  • Adjustment methods for students
    Adjustment MethodDescription
    Teaching methods

    Provide students with flexible ways of attending courses

    Assignment submission methods

    Mutual agreement to present in other ways between students and instructors

    Others

    Negotiated by both teachers and students

  • Course Schedule
    2/21Week 1總論 (一)：疫苗發展史與傳染病控制 Vaccine development and infectious disease control
    2/28Week 2國定假日
    3/6Week 3總論 (二) 台灣預防接種推動歷程與成果 Immunization programs and achievements in Taiwan
    3/13Week 4疫苗研發與製造 (一) 台灣疫苗自製政策與研發概況 (講座：國家衛生研究院生物製劑廠 江正榮執行長) Vaccine R&D and manufacturing policy in Taiwan
    3/20Week 5疫苗研發與製造 (二) 疫苗株、量產技術與品管確效 Vaccine strain preparation, vaccine manufacturing process and quality control
    3/27Week 6參訪：高端生技 Site visit: Medigen
    4/3Week 7疫苗接種政策 (一) 新疫苗的引進與接種計畫財源 Introduction of new vaccine; Funding of immunization program
    4/10Week 8疫苗接種政策 (二) 接種建議與接種計畫效益評估 Immunization recommendation; Vaccination efficacy and effectiveness
    4/17Week 9個案討論：幼兒肺炎鏈球菌疫苗列入公費接種 Case study: Introduction of PCV into NIP
    4/24Week 10習作 1. 選擇本土疫苗研發標的; 2. 決定引進公費疫苗優先順序 Exercise: 1. Funding targets for R&D; 2. Priority for new vaccine in NIP
    5/1Week 11接種計畫與實務 (一) 疫苗採購、配送與接種涵蓋率Vaccine purchasing, delivery and coverage rate;
    5/8Week 12接種計畫與實務 (二) 實務分享：BNT COVID-19疫苗運送 (裕利公司 程玉萍經理)
    5/15Week 13接種計畫與實務 (三) 大量接種與不良反應事件處理 Mass immunization and response to adverse events
    5/22Week 14個論 (一) 流感疫苗：最有效益還是最没效率？ Influenza vaccine: most effective? Or least efficient?
    5/29Week 15個論 (二) 人類乳突病毒疫苗：癌症預防與爭議 Human Papillomavirus Vaccine: cancer prevention and controversial issues
    6/5Week 16綜合討論：疫苗遲疑 (vaccine hesitancy)、新科技與緊急授權 (EUA) ; 新冠肺炎疫苗：what’s next?